These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12787824)

  • 21. A comparative analysis of the activity of ligands acting at P2X and P2Y receptor subtypes in models of neuropathic, acute and inflammatory pain.
    Andó RD; Méhész B; Gyires K; Illes P; Sperlágh B
    Br J Pharmacol; 2010 Mar; 159(5):1106-17. PubMed ID: 20136836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complexities of measuring antagonist potency at P2X(7) receptor orthologs.
    Hibell AD; Thompson KM; Xing M; Humphrey PP; Michel AD
    J Pharmacol Exp Ther; 2001 Mar; 296(3):947-57. PubMed ID: 11181928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition by ethanol of rat P2X(4) receptors expressed in Xenopus oocytes.
    Xiong K; Li C; Weight FF
    Br J Pharmacol; 2000 Jul; 130(6):1394-8. PubMed ID: 10903981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diinosine pentaphosphate (IP5I) is a potent antagonist at recombinant rat P2X1 receptors.
    King BF; Liu M; Pintor J; Gualix J; Miras-Portugal MT; Burnstock G
    Br J Pharmacol; 1999 Nov; 128(5):981-8. PubMed ID: 10556935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels.
    Lewis CJ; Evans RJ
    Br J Pharmacol; 2000 Dec; 131(8):1659-66. PubMed ID: 11139444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels.
    Nicke A; Bäumert HG; Rettinger J; Eichele A; Lambrecht G; Mutschler E; Schmalzing G
    EMBO J; 1998 Jun; 17(11):3016-28. PubMed ID: 9606184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Divergent effects of the purinoceptor antagonists suramin and pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate) (PPNDS) on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.
    Suzuki E; Kessler M; Montgomery K; Arai AC
    Mol Pharmacol; 2004 Dec; 66(6):1738-47. PubMed ID: 15448189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of potent and selective P2X₃ receptor antagonists derived from PPADS as potential pain modulators.
    Cho JH; Jung KY; Jung Y; Kim MH; Ko H; Park CS; Kim YC
    Eur J Med Chem; 2013; 70():811-30. PubMed ID: 24246730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Competitive antagonism of recombinant P2X(2/3) receptors by 2', 3'-O-(2,4,6-trinitrophenyl) adenosine 5'-triphosphate (TNP-ATP).
    Burgard EC; Niforatos W; van Biesen T; Lynch KJ; Kage KL; Touma E; Kowaluk EA; Jarvis MF
    Mol Pharmacol; 2000 Dec; 58(6):1502-10. PubMed ID: 11093790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A fluorescent approach for identifying P2X1 ligands.
    Ruepp MD; Brozik JA; de Esch IJ; Farndale RW; Murrell-Lagnado RD; Thompson AJ
    Neuropharmacology; 2015 Nov; 98():13-21. PubMed ID: 26026951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective potentiation of homomeric P2X2 ionotropic ATP receptors by a fast non-genomic action of progesterone.
    De Roo M; Boué-Grabot E; Schlichter R
    Neuropharmacology; 2010 Mar; 58(3):569-77. PubMed ID: 20004677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonism of ATP responses at P2X receptor subtypes by the pH indicator dye, Phenol red.
    King BF; Liu M; Townsend-Nicholson A; Pfister J; Padilla F; Ford AP; Gever JR; Oglesby IB; Schorge S; Burnstock G
    Br J Pharmacol; 2005 Jun; 145(3):313-22. PubMed ID: 15778739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glu496Ala polymorphism of human P2X7 receptor does not affect its electrophysiological phenotype.
    Boldt W; Klapperstück M; Büttner C; Sadtler S; Schmalzing G; Markwardt F
    Am J Physiol Cell Physiol; 2003 Mar; 284(3):C749-56. PubMed ID: 12431909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitization by extracellular Ca(2+) of rat P2X(5) receptor and its pharmacological properties compared with rat P2X(1).
    Wildman SS; Brown SG; Rahman M; Noel CA; Churchill L; Burnstock G; Unwin RJ; King BF
    Mol Pharmacol; 2002 Oct; 62(4):957-66. PubMed ID: 12237343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P2X receptor activation elicits transporter-mediated noradrenaline release from rat hippocampal slices.
    Papp L; Balázsa T; Köfalvi A; Erdélyi F; Szabó G; Vizi ES; Sperlágh B
    J Pharmacol Exp Ther; 2004 Sep; 310(3):973-80. PubMed ID: 15084650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutamate release and synapsin-I phosphorylation induced by P2X7 receptors activation in cerebellar granule neurons.
    León D; Sánchez-Nogueiro J; Marín-García P; Miras-Portugal MA
    Neurochem Int; 2008 May; 52(6):1148-59. PubMed ID: 18242779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of ATP-responses at recombinant rP2X4 receptors by extracellular pH and zinc.
    Wildman SS; King BF; Burnstock G
    Br J Pharmacol; 1999 Feb; 126(3):762-8. PubMed ID: 10188989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P2X1 receptor-mediated inhibition of the proliferation of human coronary smooth muscle cells involving the transcription factor NR4A1.
    Hinze AV; Mayer P; Harst A; von Kügelgen I
    Purinergic Signal; 2013 Dec; 9(4):677-86. PubMed ID: 23873636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P2-purinoceptor-mediated inhibition of noradrenaline release in rat atria.
    von Kügelgen I; Stoffel D; Starke K
    Br J Pharmacol; 1995 May; 115(2):247-54. PubMed ID: 7670726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conserved lysin and arginin residues in the extracellular loop of P2X(3) receptors are involved in agonist binding.
    Fischer W; Zadori Z; Kullnick Y; Gröger-Arndt H; Franke H; Wirkner K; Illes P; Mager PP
    Eur J Pharmacol; 2007 Dec; 576(1-3):7-17. PubMed ID: 17764672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.